Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones

2 hours ago

DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ shed 1.01% to $547.29 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.02% to 7,675.70 and Dow Jones Industrial Average falling 0.21% to 53,463.88.

Vertex Pharmaceuticals Inc. closed 1.51% short of its 52-week high of $555.69, which the company achieved on August 25th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. $(ABBV)$ fell 1.09% to $262.90, Krystal Biotech Inc. (KRYS) rose 1.00% to $359.76, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 2.53% to $15.83.

Trading volume (830,327) remained 771,469 below its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigermarketb.com/news/2662426817"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2662426817\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2662426817?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-27 04:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2662426817","market":"us","top_or_hot":-1,"title":"Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Vertex Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VRTX\">$(VRTX)$</a> shed 1.01% to $547.29 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&amp;P 500 Index  falling 0.02% to 7,675.70 and Dow Jones Industrial Average  falling 0.21% to 53,463.88. \n</p>\n<p>\n     Vertex Pharmaceuticals Inc. closed 1.51% short of its 52-week high of $555.69, which the company achieved on August 25th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. <a href=\"https://laohu8.com/S/ABBV\">$(ABBV)$</a> fell 1.09% to $262.90, <a href=\"https://laohu8.com/S/KRYS\">Krystal Biotech Inc.</a> (KRYS) rose 1.00% to $359.76, and Arcturus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Holdings Inc. <a href=\"https://laohu8.com/S/ARCT\">$(ARCT)$</a> rose 2.53% to $15.83. \n</p>\n<p>\n     Trading volume (830,327) remained 771,469 below its 50-day average volume of 1.6 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-08-27 04:37</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Vertex Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VRTX\">$(VRTX)$</a> shed 1.01% to $547.29 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&amp;P 500 Index  falling 0.02% to 7,675.70 and Dow Jones Industrial Average  falling 0.21% to 53,463.88. \n</p>\n<p>\n     Vertex Pharmaceuticals Inc. closed 1.51% short of its 52-week high of $555.69, which the company achieved on August 25th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. <a href=\"https://laohu8.com/S/ABBV\">$(ABBV)$</a> fell 1.09% to $262.90, <a href=\"https://laohu8.com/S/KRYS\">Krystal Biotech Inc.</a> (KRYS) rose 1.00% to $359.76, and Arcturus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Holdings Inc. <a href=\"https://laohu8.com/S/ARCT\">$(ARCT)$</a> rose 2.53% to $15.83. \n</p>\n<p>\n     Trading volume (830,327) remained 771,469 below its 50-day average volume of 1.6 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRTX","symbol_name":"福泰制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2662426817","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2662426817","pubTimestamp":1787776620,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Vertex Pharmaceuticals Inc.  shed 1.01% to $547.29 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,675.70 and Dow Jones Industrial Average  falling 0.21% to 53,463.88.Vertex Pharmaceuticals Inc. closed 1.51% short of its 52-week high of $555.69, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc.  fell 1.09% to $262.90, Krystal Biotech Inc.  rose 1.00% to $359.76, and Arcturus Therapeutics Holdings Inc.  rose 2.53% to $15.83.Trading volume  remained 771,469 below its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"VRTX":"福泰制药","VERX":"Vertex, Inc."},"translate_title":"尽管当天亏损，Vertex Pharmaceuticals Inc. 股票仍跑赢竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VERX":1.5,"VRTX":1.5},"content_text":"DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ shed 1.01% to $547.29 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,675.70 and Dow Jones Industrial Average  falling 0.21% to 53,463.88. \n\n\n     Vertex Pharmaceuticals Inc. closed 1.51% short of its 52-week high of $555.69, which the company achieved on August 25th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. $(ABBV)$ fell 1.09% to $262.90, Krystal Biotech Inc. (KRYS) rose 1.00% to $359.76, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 2.53% to $15.83. \n\n\n     Trading volume (830,327) remained 771,469 below its 50-day average volume of 1.6 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}